MAUDE Adverse Event Report: AMO MANUFACTURING NETHERLANDS TECNIS IOL; EXTENDED DEPTH OF FOCUS INTRAOCULAR LENS

Model Number	ZXT300
Medical Device Problem Code	Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes	Visual Impairment (2138); Visual Disturbances (2140); Halo (2227)
Date of Event	07/19/2021
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
Weight, and ethnicity: information unknown/not provided.If explanted; give date: n/a (not applicable).The lens remains implanted.The intraocular lens (iol) is not returning for evaluation as it remains implanted; therefore, a failure analysis of the complaint device cannot be completed.A review of the device history record, complaint trending, and risk documentation for this device will be performed.Upon completion of the review, if there is any further relevant information a supplemental medwatch will be filed.Attempts have been made to obtain missing information; however, no definitive response has been received.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
Event or Problem Description
It was reported that at the 6 month unmasked study visit, the patient's visual acuity is uncorrected distance visual acuity (ucdva) 20/25 od (right eye), 20/30 os (left eye) and best corrected distance visual acuity (bcdva) 20/20 ou (both eyes) with the intraocular lens (iol).The patient is very bothered by halos while driving at night, extremely bothered by multiple/double vision while driving and seeing clearly at distance, and extremely bothered by glare while driving after dark.There are no plans for surgical intervention.Month 1 ((b)(6) 2021) visual acuity: ucdva 20/25 ou; bcdva 20/20 od, 20/25 os.Preoperative ((b)(6) 2021) visual acuity: ucdva 20/50 od, 20/60 os; bcdva 20/25 od, 20/30 os.Patient had bilateral lens implants.This report captures the lens implanted in patients left eye.A separate report will be filed for the right eye.
Additional Manufacturer Narrative
Additional info: further information was provided and reported the subject is still driving, but they limit where they drive at night to the areas they are most familiar.Even with the reported visual issues, the subject continues to drive.Prior to the implant of the iol, the subject noted they were moderately bothered while driving at night.No other information was provided.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
Additional Manufacturer Narrative
Additional info: further information was provided that the lens was explanted as planned.A non-johnson & johnson lens was successfully implanted as a replacement.The subject denies seeing glare and halos since the explant occurred.The subject reports they are extremely happy with their visual acuity (va) after the lens exchange.Subjects best corrected visual acuity (bcva) was 20/40 ou.No other information was provided.The following sections have been updated accordingly: section d6b: if explanted, give date: (b)(6) 2021.Section h6: health effect - impact code: 4629.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
Additional Manufacturer Narrative
Additional information: additional information was provided confirming there were no unplanned sutures, vitrectomy, or incision enlargement required when removing the lens.Section d9: device available for evaluation? yes.Section d9: returned to manufacturer on: 1/6/2022.Device evaluation: the complaint lens was received inside a specimen cup.Visual inspection under magnification revealed viscoelastic residue on the optic body and haptics and that the lens was received cut into three pieces (one missing), which is consistent with a lens handled during explant.Based on the return condition of the lens, no further product evaluation could be performed on the lens.The complaint issue could not be confirmed, and no product deficiency could be identified.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.

• Brand Name: TECNIS IOL
• Common Device Name: EXTENDED DEPTH OF FOCUS INTRAOCULAR LENS
• Manufacturer (Section D): AMO MANUFACTURING NETHERLANDS; van swietenlaan 5; groningen, groningen 9728 NX; NL 9728 NX
• Manufacturer Contact: somyata nagpal ; 1700 e st andrew place; santa ana, CA 92705 ; 7142478552
• MDR Report Key: 12443828
• Report Number: 2020664-2021-07367
• Device Sequence Number: 3524963
• Product Code: POE
• UDI-Device Identifier: 05050474606456
• UDI-Public: (01)05050474606456(17)230602
• Combination Product (Y/N): N
• Initial Reporter State: FL
• Initial Reporter Country: US
• PMA/510(K) Number: P980040
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2021
• Device Explanted Year: 2021
• Serviced by Third Party (Y/N): Unknown
• Reporter Type: Manufacturer
• Report Source: Study,Health Professional,User Facility,Company Representative
• Initial Reporter Occupation: Physician
• Type of Report: Initial,Followup,Followup,Followup
• Report Date (Section B): 02/28/2022

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Health Professional
• Device Expiration Date: 06/02/2023
• Device Model Number: ZXT300
• Device Catalogue Number: ZXT300U235
• Was Device Available for Evaluation?: Device Returned to Manufacturer
• Date Returned to Manufacturer: 01/06/2022
• Is the Reporter a Health Professional?: Yes
• Was the Report Sent to FDA?: No
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 08/10/2021
• Supplement Date Received by Manufacturer: 09/09/2021; 01/28/2022; 02/02/2022
• Initial Report FDA Received Date: 09/08/2021
• Supplement Report FDA Received Date: 10/01/2021; 02/02/2022; 02/28/2022
• Was Device Evaluated by Manufacturer? (Y/N): Device Not Returned to Manufacturer
• Date Device Manufactured: 06/02/2018
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Other
• Patient Sex: Female